Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer

NCT00331552 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: pegylated liposomal doxorubicin hydrochloride
DRUG: cyclophosphamide
BIOLOGICAL: trastuzumab

Sponsor

University of Washington

Collaborators

[object Object]